CADONILIMAB

Search structure
Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 6FYG1DS4NW

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Cytotoxic T-lymphocyte protein 4 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Uterine Cervical Neoplasms 3 D002583 ClinicalTrials
Uterine Cervical Neoplasms 3 D002583 ClinicalTrials
Uterine Cervical Neoplasms 3 D002583 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Nasopharyngeal Carcinoma 3 D000077274 ClinicalTrials
Adenocarcinoma 3 D000230 ClinicalTrials
Carcinoma, Hepatocellular 3 D006528 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Cholangiocarcinoma 2 D018281 ClinicalTrials
Melanoma 2 D008545 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Biliary Tract Neoplasms 2 D001661 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Mesothelioma 2 D008654 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Nasopharyngeal Neoplasms 2 D009303 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Urinary Bladder Neoplasms 2 D001749 ClinicalTrials
Urinary Bladder Neoplasms 2 D001749 ClinicalTrials
Vulvar Neoplasms 2 D014846 ClinicalTrials
Urinary Bladder Neoplasms 2 D001749 ClinicalTrials
Small Cell Lung Carcinoma 1 D055752 ClinicalTrials
Lymphoma, T-Cell, Peripheral 1 D016411 ClinicalTrials
Glioblastoma 1 D005909 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594456
FDA SRS 6FYG1DS4NW
CONTENTS